Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Inherited defects of thyroid hormone-cell-membrane transport: review of recent findings.
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.
Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation.
Rationale, Opportunities, and Reality of Biosimilar Medications.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rationale, Opportunities, and Reality of Biosimilar Medications.
Rationale, Opportunities, and Reality of Biosimilar Medications. N Engl J Med. 2018 May 24; 378(21):2036-2044.
View in:
PubMed
subject areas
Attitude of Health Personnel
Biosimilar Pharmaceuticals
Drug Approval
Drug Industry
Drug Labeling
Government Regulation
Health Knowledge, Attitudes, Practice
Humans
United States
United States Food and Drug Administration
authors with profiles
Richard Schilsky